authorized generics News
Most Popular authorized generics Story
J&J fights Teva with generic Risperdal
It's a watershed moment: Risperdal has gone generic. The Johnson & Johnson antipsychotic med now has copycat competition from Teva Pharmaceutical Industries, which got the final FDA go-ahead Read more...
Latest Headlines
- September 1, 2011
- April 11, 2011
- October 16, 2009
- October 5, 2009
- August 11, 2009
- June 24, 2009
- June 4, 2009
- March 31, 2009
- December 2, 2008
- July 1, 2008
- June 24, 2008
- May 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
